Ocuphire Pharma Inc
NASDAQ:OCUP 4:00:00 PM EDT
| Market Cap (Intraday) | 40.94M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 1.36 |
| 10-Day MA | $1.64 |
| 50-Day MA | $2.03 |
| 200-Day MA | $2.98 |
Ocuphire Pharma Inc Stock, NASDAQ:OCUP
37000 Grand River Avenue, Suite 120, Farmington Hills, Michigan 48335
United States of America
Phone: +1.248.681.9815
Number of Employees: 14
Description
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.